Literature DB >> 16376880

The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc.

Neetu Kalra1, Vijay Kumar.   

Abstract

The HBx protein of hepatitis B virus is involved in deregulation of cell cycle and development of hepatocellular carcinoma. Since c-Myc also plays an important role in cell proliferation and tumor development, we studied its regulation by HBx in a human hepatoma cell line. Co-expression of HBx and c-Myc resulted in increased stability of intracellular c-Myc. HBx blocked the ubiquitination of Myc through a direct interaction with the F box region of Skp2 and destabilization of the SCF(Skp2) complex. We suggest that sustained presence of c-Myc combined with mitogenic activity inherent to HBx may be associated with cell cycle deregulation and transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16376880     DOI: 10.1016/j.febslet.2005.12.034

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Partial molecular characterization, expression pattern, polymorphism and association analysis of porcine SKP2 gene.

Authors:  Y Li; S L Yang; Z L Tang; W T Cui; Y L Mu; M X Chu; S H Zhao; Z F Wu; K M Peng; K Li
Journal:  Mol Biol Rep       Date:  2009-03-26       Impact factor: 2.316

2.  The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.

Authors:  Azfar Jamal; Manickavinayaham Swarnalatha; Sarwat Sultana; Prashant Joshi; Subrat K Panda; Vijay Kumar
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.

Authors:  Jason Lamontagne; Laura F Steel; Michael J Bouchard
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

4.  The Smad7-Skp2 complex orchestrates Myc stability, impacting on the cytostatic effect of TGF-β.

Authors:  Tae-Aug Kim; Jin Muk Kang; Ja-Shil Hyun; Bona Lee; Staci Jakyong Kim; Eun-Sung Yang; Suntaek Hong; Ho-Jae Lee; Makiko Fujii; John E Niederhuber; Seong-Jin Kim
Journal:  J Cell Sci       Date:  2013-11-20       Impact factor: 5.285

5.  Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability.

Authors:  Petra Baresova; Paula M Pitha; Barbora Lubyova
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

6.  Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.

Authors:  S Lee; W Kim; C Ko; W-S Ryu
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

Review 7.  Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.

Authors:  Yi Tian; Weibing Yang; Jianxun Song; Yuzhang Wu; Bing Ni
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

8.  Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells.

Authors:  Lian Yang; Jun He; Libo Chen; Guobin Wang
Journal:  Med Oncol       Date:  2008-12-13       Impact factor: 3.064

9.  Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx.

Authors:  Takahisa Kouwaki; Toru Okamoto; Ayano Ito; Yukari Sugiyama; Kazuo Yamashita; Tatsuya Suzuki; Shinji Kusakabe; Junki Hirano; Takasuke Fukuhara; Atsuya Yamashita; Kazunobu Saito; Daisuke Okuzaki; Koichi Watashi; Masaya Sugiyama; Sachiyo Yoshio; Daron M Standley; Tatsuya Kanto; Masashi Mizokami; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

10.  Adenovirus E4orf4 protein downregulates MYC expression through interaction with the PP2A-B55 subunit.

Authors:  Haggit Ben-Israel; Rakefet Sharf; Gideon Rechavi; Tamar Kleinberger
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.